Antitussive Drugs Market to Grow with a CAGR of 5.25% through 2028
Increasing Prevalence
of Respiratory Diseases and Infections and increase in the aging population is
expected to drive the Global Antitussive Drugs Market growth in the forecast
period, 2024-2028.
According to
TechSci Research report, “Antitussive Drugs Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2028”, the
Global Antitussive Drugs Market stood at USD 1.45 billion in 2022 and is
anticipated to grow with a CAGR of 5.25% in the forecast period, 2024-2028. The
awareness among individuals regarding Antitussive Drugs has led to favorable
market conditions for the global Antitussive Drugs market. Several factors
contribute to the growth of various Antitussive Drugs products.
The global
antitussive drugs market is experiencing increased demand due to the rising
burden of respiratory diseases. Factors such as air pollution, smoking habits,
and aging populations have contributed to this trend. One of the primary
catalysts driving the growth of this market is the prevalence of respiratory
diseases and infections. Conditions like asthma, chronic obstructive pulmonary
disease (COPD), bronchitis, and pneumonia frequently result in persistent and
distressing coughing episodes. In response to these symptoms, healthcare
providers often prescribe antitussive drugs to effectively manage coughing and
enhance the overall quality of life for patients.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Antitussive Drugs Market.”
The worsening
air quality in many cities around the world has led to an increased prevalence
of respiratory symptoms and diseases, thereby boosting the demand for
antitussive drugs as a means to alleviate coughing associated with
pollution-related health issues, which will further fuel market growth.
In September
2023, Teva will present data for AUSTEDO® XR (deutetrabenazine)
extended-release tablets, AUSTEDO® (deutetrabenazine) capsules, and AUSTEDO®
(deutetrabenazine) oral solution at the 34th European College of
Neuropsychopharmacology (ECNP) Congress. The data will highlight the efficacy,
safety, and tolerability of AUSTEDO® in patients with Huntington's disease and
tardive dyskinesia.
Improved access
to healthcare facilities, including pharmacies and over-the-counter (OTC)
products, also contributes to the growth of the antitussive drugs market.
Consumers can readily purchase cough suppressants, making these medications
more accessible and convenient.
In today's
fast-paced world, In a world where time is of the essence, constant coughing
can be not only physically uncomfortable but also socially disruptive.
Antitussive drugs help individuals manage coughing symptoms efficiently,
allowing them to focus on their tasks without the distraction of persistent
coughing. For professionals and workers in various industries, an uninterrupted
workflow is crucial. Coughing fits can disrupt concentration, meetings, and
deadlines. Antitussive medications enable individuals to maintain their
productivity levels by minimizing or eliminating disruptive coughing spells. In
our fast-paced world, restorative sleep is essential for mental alertness and
physical well-being. Coughing can disrupt sleep patterns, leading to fatigue
and decreased productivity during the day. Antitussive drugs can provide
uninterrupted sleep, ensuring individuals wake up refreshed and ready to face
their daily challenges. Effective communication is vital in both personal and
professional settings. Chronic coughing can hinder clear and productive
communication. Antitussive medications help individuals communicate more
effectively, whether in business meetings, social gatherings, or everyday
conversations. In social situations, persistent coughing can lead to
embarrassment and social discomfort. Antitussive drugs offer relief from
coughing, enabling individuals to participate in social events and interactions
with confidence.
The convenience
of antitussive drugs, available in various formulations like tablets, syrups,
and lozenges, allows individuals to choose the most suitable option for their
lifestyle and preferences. This convenience aligns with the fast-paced nature
of modern life.
In recent times,
Antitussive drugs are commonly prescribed to individuals with respiratory
infections, including the flu and common cold. These medications help alleviate
coughing, making patients more comfortable during the course of the illness. Patients
with chronic respiratory conditions like asthma, chronic obstructive pulmonary
disease (COPD), and bronchitis often experience persistent coughing.
Antitussive drugs are used as part of the treatment regimen to manage this
troublesome symptom. Allergic reactions to environmental allergens or irritants
can lead to coughing fits. Antitussive medications help reduce coughing
episodes, providing relief to individuals with allergies. After surgical
procedures, coughing can strain incisions and sutures. Antitussive drugs may be
prescribed to post-operative patients to minimize coughing and support the
healing process. However, the Regulatory Hurdles and Stringent Approvals may
hinder market growth. Moreover, challenges related to Increasing Competition
and Generic Substitution and Evolving Healthcare Trends may pose obstacles to
the Antitussive Drugs market in the near future.
The Global Antitussive
Drugs Market is segmented into Drug class, route of administration, age group, end-user,
regional distribution, and company.
Based on its drug
class, the Peripherally acting drugs have become dominant in the global
antitussive drug market due to several factors that enhance their
effectiveness, safety, and market appeal. Peripherally acting antitussive drugs
primarily target the cough reflex at the level of the peripheral nervous system
or the respiratory tract. Peripherally acting antitussive drugs typically do
not exert their effects on the central nervous system (CNS) to the same extent
as centrally acting drugs, particularly opioids. This reduced central nervous
system penetration results in a lower risk of side effects like drowsiness,
sedation, and dependence, making peripherally acting drugs a safer option for a
broader patient population. Many peripherally acting antitussive drugs do not
contain opioids, which have faced increasing scrutiny due to their potential
for abuse and addiction. Non-opioid antitussive options align with evolving
healthcare trends focused on minimizing opioid usage, especially in cases where
alternatives are available.
Based on region,
North America segment is expected to grow during the forecast
period. North America, including The United States and Canada has
been a dominant region in the global antitussive drugs market. Reasons for
dominance include a large population, a high prevalence of respiratory
conditions like asthma and chronic obstructive pulmonary disease (COPD), and a
well-developed healthcare infrastructure. The region's strong pharmaceutical
industry, coupled with a high level of healthcare expenditure, has contributed
to the prominence of North America in the market.
The Asia-Pacific
market is poised to be the fastest-growing market, offering lucrative growth
opportunities for Antitussive Drugs players during the forecast period. Factors
such as The Asia-Pacific region is home to a significant portion of the world's
population, including a growing elderly demographic. Aging populations are more
susceptible to respiratory conditions, including chronic coughing, which drives
the demand for antitussive medications. Rapid industrialization, urbanization,
and environmental pollution have led to a rise in respiratory health concerns
in many Asia-Pacific countries. Poor air quality, exacerbated by pollution,
contributes to higher incidences of respiratory conditions and coughing,
necessitating the use of antitussive drugs. Improvements in healthcare access
and awareness in the Asia-Pacific region have led to earlier diagnosis and
treatment of respiratory conditions. Patients and healthcare providers have
become more aware of the importance of managing coughing and related symptoms,
driving the demand for antitussive drugs.
Major companies
operating in Global Antitussive Drugs Market are:
- Teva Pharmaceutical Industries Ltd.
- Intas Pharmaceuticals Ltd.
- Bayer AG
- Ipca Laboratories Ltd.
- F. Hoffmann-La Roche Ltd.
- Hikma Pharmaceuticals PLC
- Unique Pharmaceuticals Limited
- Cipla Inc.
- Mylan N.V.
- Aurobindo Pharma
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The Consumer
Awareness and Accessibility and increasing pollution level are key drivers of
the Antitussive Drugs market. In recent years, Growing awareness of respiratory
health issues and the availability of antitussive drugs, including
over-the-counter options, influence market demand. Ongoing research
and development efforts lead to the introduction of new antitussive medications,
expanding the market. Moreover, the growing consumer emphasis on preventative
healthcare products has enhanced production and marketing efforts. To meet the
demands of the market, manufacturers are increasingly incorporating
cutting-edge technologies with high production efficiency. Rising consumer
acceptance and continuous product innovation will further ensure the growth of
the Antitussive Drugs and supplements market in the coming years.,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Antitussive
Drugs Market – Global Industry Size, Share, Trends, Opportunity, & Forecast
2018-2028 Segmented By Drug Class (Peripherally Acting Drugs, Centrally Acting
Drugs, Others), By Route of Administration (Inhalational, Oral, Others), By Age
Group (Geriatric, Pediatric, Adult), By End-User (Homecare, Hospitals &
Specialty Clinics, Others), By Region, Competition”, has evaluated
the future growth potential of Global Antitussive Drugs Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Antitussive Drugs Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com